CD45 expression was scored in 44 pretreatment rectal cancer biopsy samples by performing costaining with EpCAM antibodies (Figure 2A), and the tumor regression grade (TRG) was pathologically determined in surgically removed specimens according to the American Joint Committee on Cancer tumor regression grading system 15. Here, PTPRC is linked to rectal cancer.